The primary aim of the MRI group is the development and implementation of new methods, hardware and sequences in magnetic resonance imaging with a focus on the brain.
Magnetoencephalography (MEG) is a non-invasive measurement for the detection of the tiny magnetic field components originated from the information processes in the living human brain.
The special field of interest of this group is the preclinical and clinical testing of new radiopharmaceuticals for nuclear medicine diagnostics of brain tumours using Positron-Emission-Tomography (PET) and correlation with Magnetic Resonance Imaging (MRI).
The working group "Clinical Multimodal Imaging" is primarily concerned with research into individual biomarkers in order to apply individually optimised therapy for patients with psychiatric disorders and also to evaluate treatment success.
